Arbor Capital Management Inc Pfizer Inc Transaction History

Arbor Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $12,942 - $16,895	-310 Reduced 6.32%	4,594 $235,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $203,177 - $248,029	-4,643 Reduced 48.63%	4,904 $217,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $1.32 Million - $1.56 Million	-28,333 Reduced 74.8%	9,547 $501,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $904,935 - $1.12 Million	-19,780 Reduced 34.3%	37,880 $1.94 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $2.38 Million - $3.53 Million	57,660 New	57,660 $3.41 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Arbor Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Arbor Capital Management Inc with notifications on news.